The Peptide List is the bootstrapped outlier in a category where VCs are pouring money: Cradle Bio - $103M raised for AI protein and peptide design Profluent - $150M Series B (backed by Bezos Expeditions) for generative protein and peptide models Pepticom - $6.6M Series A1 for the world's first AI-designed peptide for psoriasis This matters because: Over $7B has gone into peptide drug startups since 2020, but no peptide information platform has been funded yet - the trust layer is wide open Brian Sugar of Sugar Capital is publicly calling peptides the next 'great consumer health category' and asking founders to reach out Zocdoc proved a healthcare provider directory can be worth $1.8B

GLP-1 weight loss programs are ideal for adults who: Struggle with appetite control or plateaued weight loss Have difficulty managing blood sugar levels Want to lose weight safely under medical supervision Prefer a structured, science-based approach over crash diets Your provider will help determine whether semaglutide-based treatment is the right fit for you
Compound-level research most associates the GLOW combination with soft-tissue repair coverage, collagen and skin-quality remodeling driven by GHK-Cu, anti-inflammatory pathway overlap, and organized matrix formation
Baseline glutathione (GSH/GSSG ratio), cysteine, homocysteine, and markers of oxidative stress (oxidized glutathione, lipid peroxides) help providers assess true deficiency
Most patients can resume normal activities shortly after the procedure due to minimal downtime